BioInformant is honored to be a sponsor for the upcoming “Perinatal Stem Cell Society Conference” in Aspen, Colorado, over March 2-4, 2016. This 3-day event will feature the world’s leading perinatal stem cell researchers, specializing in Amnion, Amniotic fluid, Cord Blood for Regenerative Medicine, Cord Tissue, and the Placenta. BioInformant’s sponsorship of the event is in collaboration with Save the Cord Foundation, as part of our partnership to promote cord blood banking awareness around the world.
The Perinatal Stem Cell Society was founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped life potential to treat many disorders. It will be hosting a scientific program with topics covering all aspects of the perinatal stem cell field. Attendees are actively advancing perinatal stem cell research, and focused on paths towards treatment.
“Perinatal stem cells represent one of the single most promising areas of stem cell research. These stem cells, which includes include cells derived from amniotic fluid, placenta, and umbilical cord, will fundamentally impact the field of regenerative medicine over the next 5-10 years. While perinatal stem cells are largely recognized for their therapeutic potential, these cells will also shape the fields of drug discovery and toxicology.”
–Cade Hildreth, President/CEO of BioInformant
Featured speakers for the event will include:
- C. Randal Mills, PhD: President and Chief Executive Officer of the California Institute of Regenerative Medicine
- Robert Hariri, MD, PhD: The Chairman, Founder, and Chief Scientific Officer. Also former Chief Executive Officer of Celgene Cellular Therapeutics
- Joanne Kurtzberg, MD: Director of the Pediatric Blood and Marrow Transplant Program, Chief Scientific and Medical Officer of the Robertson Clinical and Translational Cell Therapy Program at Duke University
To learn more about the conference or to see a full schedule of spearkers, visit: http://perinatalstemcells.com
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant has been cited by prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, CBS News, and the California Institute for Regenerative Medicine (CIRM).